The records and immunological lab reports from 18 adult PASC patients treated with maraviroc 300 mg per oral twice daily and pravastatin 10 mg per oral daily from our virtual medical clinic were collected and analyzed.
The 18 participants selected for this case series were from a pool of patients who reported symptom improvement while on maraviroc and pravastatin and who fit the inclusion and exclusion criteria we set below.
The 18 participants selected for this case series were from a pool of patients who reported symptom improvement while on maraviroc and pravastatin and who fit the inclusion and exclusion criteria we set below.
Free full text: Click here
